Fremont, Calif.-based Optovue Inc. received 510(k) clearance for Angioanalytics, an optical coherence tomography angiography (OCTA) blood vessel measurement technology to help manage diseases that cause progressive blindness. In addition, the agency has given the green light to the company's three-dimensional projection artifact removal (3D PAR) software, which aims to boost OCTA image quality. Read More
